SEC Form 5 · accession 0001140361-16-052410
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — SVP, General Counsel
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 16, 2015 | G | 75 | $0.00 | D | 66,081 | D | |
| Common StockF2 | Jul 24, 2015 | G | 105 | $0.00 | D | 65,976 | D | |
| Common StockF3 | Oct 31, 2015 | A | 18 | $51.2635 | A | 65,994 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 16, 2015, the reporting person gifted 75 shares to a university.
- F2On July 24, 2015, the reporting person gifted 105 shares to a fraternity foundation.
- F3Represents shares acquired by the reporting person on October 31, 2015, pursuant to the issuer's Employee Stock Purchase Plan.